Literature DB >> 456053

Pulmonary alveolar proteinosis: abnormal in vitro function of alveolar macrophages.

J O Harris.   

Abstract

Pulmonary alveolar proteinosis is characterized by the accumulation of granular proteinaceous material within the alveoli of the lung. It is well established that patients with pulmonary alveolar proteinosis have a high incidence of complicating pulmonary infections, which suggests that the function of the alveolar macrophages is abnormal. To investigate the function of these cells, they were obtained from two patients by pulmonary lavage with physiologic saline solution and were incubated with Staphylococcus aureus in vitro. The decline in viable organisms from the culture was measured and compared with results obtained with normal alveolar macrophages. On the basis of decreased phagocytosis, results indicate that pulmonary alveolar macrophages from these patients had defective antibacterial function.

Entities:  

Mesh:

Year:  1979        PMID: 456053     DOI: 10.1378/chest.76.2.156

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation.

Authors:  M Luisetti; M Salmona; E Pozzi; M Genghini; L Spialtini; P Masturzo
Journal:  Lung       Date:  1987       Impact factor: 2.584

3.  Pulmonary alveolar proteinosis: determination of prostaglandins and leukotrienes in lavage fluid.

Authors:  F J Zijlstra; J E Vincent; B van den Berg; H C Hoogsteden; H J Neyens; J J van Dongen
Journal:  Lung       Date:  1987       Impact factor: 2.584

4.  GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS.

Authors:  Pierre-Yves Berclaz; Brenna Carey; Marie-Dominique Fillipi; Kara Wernke-Dollries; Nick Geraci; Stephanie Cush; Terry Richardson; Joe Kitzmiller; Michael O'connor; Christina Hermoyian; Thomas Korfhagen; Jeffrey A Whitsett; Bruce C Trapnell
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-17       Impact factor: 6.914

Review 5.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

6.  Surfactant apoprotein in nonmalignant pulmonary disorders.

Authors:  G Singh; S L Katyal
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

7.  Pulmonary alveolar proteinosis as an unusual pattern of lung involvement in Sjögren syndrome.

Authors:  Eugene Park; Hae-Rim Kim; Hee Joung Kim; Sang-Heon Lee
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

8.  A macrophage-suppressing 40-kD protein in a case of pulmonary alveolar proteinosis.

Authors:  J Müller-Quernheim; R E Schopf; P Benes; V Schulz; R Ferlinz
Journal:  Klin Wochenschr       Date:  1987-10-01

9.  Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression.

Authors:  U Dirksen; R Nishinakamura; P Groneck; U Hattenhorst; L Nogee; R Murray; S Burdach
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

Review 10.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.